AptarGroup (NYSE:ATR) Issues Q2 Earnings Guidance

AptarGroup (NYSE:ATR) issued an update on its second quarter earnings guidance on Thursday morning. The company provided EPS guidance of $1.30-$1.38 for the period, compared to the consensus EPS estimate of $1.36. AptarGroup also updated its Q2 2024 guidance to 1.300-1.380 EPS.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ATR. Robert W. Baird upgraded AptarGroup from a neutral rating to an outperform rating and increased their price objective for the company from $125.00 to $150.00 in a report on Wednesday, January 3rd. Wells Fargo & Company increased their price target on shares of AptarGroup from $157.00 to $160.00 and gave the company an overweight rating in a research note on Thursday, March 7th.

AptarGroup Stock Performance

NYSE ATR traded up $3.15 during trading hours on Friday, hitting $143.33. The company had a trading volume of 489,509 shares, compared to its average volume of 316,865. The business has a 50 day moving average of $140.97 and a 200-day moving average of $132.13. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.83 and a current ratio of 1.24. AptarGroup has a 1-year low of $111.63 and a 1-year high of $148.51. The company has a market cap of $9.48 billion, a PE ratio of 30.76, a price-to-earnings-growth ratio of 3.93 and a beta of 0.59.

AptarGroup (NYSE:ATR) last released its quarterly earnings results on Friday, February 9th. The industrial products company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.12 by $0.09. The company had revenue of $838.48 million for the quarter, compared to analyst estimates of $842.50 million. AptarGroup had a return on equity of 15.26% and a net margin of 8.83%. The firm’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.92 earnings per share. As a group, equities research analysts expect that AptarGroup will post 5.21 EPS for the current year.

AptarGroup Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 16th. Stockholders of record on Thursday, April 25th will be given a dividend of $0.41 per share. The ex-dividend date is Wednesday, April 24th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.14%. AptarGroup’s payout ratio is 35.19%.

Insider Buying and Selling

In other news, CEO Stephan B. Tanda sold 32,000 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the completion of the transaction, the chief executive officer now directly owns 159,024 shares of the company’s stock, valued at approximately $22,528,930.08. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other AptarGroup news, insider Gael Touya sold 3,500 shares of the company’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $142.84, for a total value of $499,940.00. Following the transaction, the insider now directly owns 33,426 shares in the company, valued at approximately $4,774,569.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Stephan B. Tanda sold 32,000 shares of AptarGroup stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the sale, the chief executive officer now owns 159,024 shares of the company’s stock, valued at $22,528,930.08. The disclosure for this sale can be found here. Insiders have sold a total of 37,500 shares of company stock worth $5,318,280 in the last quarter. Company insiders own 1.00% of the company’s stock.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.